Skip to main content

Table 1 Publications using humanized mouse/cells

From: Characterization and applications of chimeric mice with humanized livers for preclinical drug development

Chimeric mice or cells

PXB-mouse

FRG mouse

TK-NOG mouse

uPA/SCID mouse (CA)a

uPA/SCID mouse (DE)b

uPA/SCID mouse (BE)c

uPA/SCID mouse (FR)d

PXB-cells

Total

Anti-HBV agents

 Nucleic acid analog

2

0

0

0

2

0

0

1

5

 Small molecule

7

1

0

0

0

0

0

10

18

 Interferon

3

0

0

0

3

0

0

0

6

 siRNA/miRNA

2

1

1

0

0

0

0

2

6

 Antibody

1

1

0

0

0

0

0

0

2

 Others

0

1

0

0

6

0

0

0

7

Ant-HCV agents

 Small molecule

24

3

2

3

0

4

1

0

37

 Interferon

5

0

0

2

1

0

0

0

8

 Small molecule +Interferon

4

0

1

0

0

0

0

0

5

 siRNA

4

1

0

0

0

0

0

0

5

 Antibody

3

3

0

3

1

9

0

0

19

 Others

2

0

0

0

0

0

0

0

2

DMPK/Toxicology

 ADME

24

3

11

0

0

10

0

2

50

 DDI

5

0

3

0

0

0

0

1

9

 Liver toxicity

19

0

5

0

0

0

0

0

24

Total

105

14

23

8

13

23

1

16

203

  1. a KMT Hepatech, b University Medical Center Hamburg-Eppendorf, c Ghent University, d Inserm